Search

everythinglearnresearchcommunity

for

Search:↓

IP-PA1 helps grow hair in mice and affects human cell growth-related genes differently than traditional hair growth treatments.

The specific skin disease variant p.(Arg2000Trp) in plectin can cause a wide range of symptoms, which should be considered when diagnosing patients.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

RPGRIP1L helps skin cells stick together by blocking PKCβII, which can prevent skin blistering like in pemphigus.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

A new syndrome was linked to two new genetic changes in the MBTPS1 gene in a 14-year-old girl.

CAP1/Prss8 does not activate PAR2 or inhibit PN-1.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

The enzyme PA-PLA1α is important for proper hair follicle development.

NAG-1 may help prevent some metabolic issues related to PCOS.

PADI4 enzyme slows down cell growth in developing hair follicles.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

The revised BASP classification for hair loss is less accurate and harder to use but could still be a viable option.

Blocking BACE1 and BACE2 enzymes causes hair color loss in mice.

EBF1 controls hair type and length.

p2y5, now called LPA6, is a receptor important for human hair growth.

Low doses of BPA can increase prostate growth and change hormone levels in adult rats.

Brg1 is crucial for hair growth and skin repair by maintaining stem cells and promoting regeneration.

The formulation helps improve wound healing and skin repair.

Two genes, ERBB4 and ROR1, may cause the unique pigmentation in Lanping black-boned sheep.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

BAP1 mutations are rare in pediatric melanocytic tumors and may develop later in life.

PAD3 plays a key role in hair and skin protein structure and may be linked to skin diseases.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Upadacitinib effectively treats pyoderma gangrenosum.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Increased PPARGC1α relates to hair thinning in common baldness.